Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Big Pharma ROI for drug R&D saw surprise rebound in 2023: report
The 2023 figures are now in and they suggest the picture isn’t as bleak as feared
James Waldron
Apr 25, 2024 12:01am
How Vertex became the VIP of Alpine's exclusive data room
Apr 23, 2024 11:19am
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Apr 23, 2024 10:43am
Biopharma M&A more than doubled in Q1 compared to a year ago
Apr 18, 2024 9:46am
Deep dive: Biopharma layoffs in Q1
Apr 12, 2024 9:00am
Vertex pays $4.9 billion to hike Alpine’s immunology trail
Apr 10, 2024 5:30pm